Citadel Advisors’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $696K | Buy |
|
|||||
|
2024
Q3 | $165K | Sell |
|
|||||
|
2024
Q2 | $863K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25.4K | Buy |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.03K | Sell |
|
|||||
|
2022
Q4 | $4.65K | Sell |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $31K | Sell |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $496K | Buy |
|
|||||
|
2021
Q3 | $540K | Sell |
|
|||||
|
2021
Q2 | $1.04M | Sell |
|
|||||
|
2021
Q1 | $3.89M | Buy |
|
|||||
|
2020
Q4 | $3.21M | Sell |
|
|||||
|
2020
Q3 | $4.35M | Sell |
|
|||||
|
2020
Q2 | $18M | Sell |
|
|||||
|
2020
Q1 | $11.2M | Buy |
|
|||||
|
2019
Q4 | $3.04M | Sell |
|
|||||
|
2019
Q3 | $4.58M | Buy |
|
|||||
|
2019
Q2 | $223K | Sell |
|
|||||
|
2019
Q1 | $107K | Sell |
|
|||||
|
2018
Q4 | $4.77M | Buy |
|
|||||
|
2018
Q3 | $4.94M | Sell |
|
|||||
|
2018
Q2 | $10.9M | Buy |
|
|||||
|
2018
Q1 | $7.97M | Buy |
|
|||||
|
2017
Q4 | $165K | Buy |
|
|||||
|
2017
Q3 | $37K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $58K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $330K | Buy |
|
|||||
|
2015
Q1 | $324K | Sell |
|
|||||
|
2014
Q4 | $2.59M | Buy |
|
|||||
|
2014
Q3 | $1.58M | Buy |
|